I agree that this site is using cookies. You can find further informations here.
X
Terzolo, S.
138  results:
Search for persons X
?
1

Adoption of electronic patient-reported outcomes in cancer ..:

Valsecchi, A.A. ; Battista, V. ; Terzolo, S....
ESMO Real World Data and Digital Oncology.  3 (2024)  - p. 100025 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Confirmatory validation analysis of the PROFFIT questionnai..:

Arenare, L. ; Porta, C. ; Barberio, D....
ESMO Open.  8 (2023)  6 - p. 102192 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Confirmatory validation analysis of the PROFFIT questionnai..:

Arenare, L ; Porta, C ; Barberio, D...
https://research.stmarys.ac.uk/id/eprint/6162/1/PIIS2059702923014333.pdf.  , 2023
Link: https://research.stmarys..
 
?
4

Confirmatory validation analysis of the PROFFIT questionnai..:

Arenare, L ; Porta, C ; Barberio, D...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10774953/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
5

34P Impact of environmental pollution on adrenocortical car..:

Puglisi, S. ; Calabrese, A. ; Ferraù, F....
ESMO Open.  9 (2024)  - p. 102423 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Disease control of acromegaly does not prevent excess morta..:

Arosio, M. ; Sciannameo, V. ; Contarino, A....
Journal of Endocrinological Investigation.  47 (2024)  6 - p. 1457-1465 , 2024
Link: https://doi.org/10.1007/..
 
?
7

38P Venous thromboembolism in patients with adrenocortical ..:

Trevisan, B. ; Kimpel, O. ; Puglisi, S....
ESMO Open.  9 (2024)  - p. 102560 , 2024
Link: https://doi.org/10.1016/..
 
?
8

35P ABACUS trial: Abiraterone acetate in the management of ..:

Cosentini, D. ; Puglisi, S. ; Grisanti, S....
ESMO Open.  9 (2024)  - p. 102424 , 2024
Link: https://doi.org/10.1016/..
 
?
9

29MO Germline variants NGS characterization in patients wit..:

Grisanti, S. ; Scatolini, M. ; Tomaiuolo, P....
ESMO Open.  8 (2023)  1 - p. 101050 , 2023
Link: https://doi.org/10.1016/..
 
?
10

S-GRAS score for prognostic classification of adrenocortica..:

Elhassan, Y S ; Altieri, B ; Berhane, S...
European Journal of Endocrinology.  186 (2022)  1 - p. 25-36 , 2022
Link: https://doi.org/10.1530/..
 
?
11

Phase II study of cabazitaxel as second-third line treatmen..:

Laganà, M. ; Grisanti, S. ; Ambrosini, R....
ESMO Open.  7 (2022)  2 - p. 100422 , 2022
Link: https://doi.org/10.1016/..
 
?
12

May an adrenal incidentaloma change its nature?:

Müller, A. ; Ingargiola, E. ; Solitro, F....
Journal of Endocrinological Investigation.  43 (2020)  9 - p. 1301-1307 , 2020
Link: https://doi.org/10.1007/..
 
?
13

What factors have impact on glucocorticoid replacement in a..:

Puglisi, S. ; Rossini, A. ; Tabaro, I....
Journal of Endocrinological Investigation.  44 (2020)  4 - p. 865-872 , 2020
Link: https://doi.org/10.1007/..
 
?
14

New perspectives for mitotane treatment of adrenocortical c..:

Puglisi, S. ; Calabrese, A. ; Basile, V....
Best Practice & Research Clinical Endocrinology & Metabolism.  34 (2020)  3 - p. 101415 , 2020
Link: https://doi.org/10.1016/..
 
?
15

Mitotane: new facts for an old drug:

Calabrese, A. ; Puglisi, S. ; Basile, V...
Current Opinion in Endocrine and Metabolic Research.  8 (2019)  - p. 145-151 , 2019
Link: https://doi.org/10.1016/..
 
1-15